Therapeutic manipulation of the HIF hydroxylases.

Therapeutic manipulation of the HIF hydroxylases.

The hypoxia-inducible factor (HIF) family of transcription factors is responsible for coordinating the cellular response to low oxygen levels in animals. By regulating the expression of a large array of target genes during hypoxia, these proteins also direct adaptive changes in the hematopoietic, ca...

Full description

Bibliographic Details
Main Authors:	Nagel, S, Talbot, N, Mecinović, J, Smith, T, Buchan, A, Schofield, C
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Signalling hypoxia by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2005)

Oxygen sensing by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2004)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
by: Chen, R, et al.
Published: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
by: Chen, R, et al.
Published: (2014)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Studies on HIF hydroxylases
by: Webb, J
Published: (2008)

Inhibition of hypoxia inducible factor (HIF) hydroxylases
by: Conejo-Garcia, A, et al.
Published: (2005)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
by: McNeill, L, et al.
Published: (2002)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
by: Mole, D, et al.
Published: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
by: Schlemminger, I, et al.
Published: (2003)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
by: Mecinovic, J, et al.
Published: (2007)

Pharmacological targeting of the HIF hydroxylases - A new field in medicine development.
by: Chan, M, et al.
Published: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
by: Yeoh, K, et al.
Published: (2013)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
by: Cockman, M, et al.
Published: (2019)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Regulation of HIF: prolyl hydroxylases.
by: Stolze, I, et al.
Published: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
by: Chan, M, et al.
Published: (2016)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
by: Mecinovic, J, et al.
Published: (2008)

Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.
by: Webb, J, et al.
Published: (2009)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
by: Matthew E Cockman, et al.
Published: (2019-09-01)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
by: Flashman, E, et al.
Published: (2010)

The HIF hydroxylase pathway and the tumour microenvironment
by: Ratcliffe, P
Published: (2008)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
by: Hewitson, K, et al.
Published: (2002)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Chowdhury, R, et al.
Published: (2016)

The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.
by: Masson, N, et al.
Published: (2012)

The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity
by: Masson, N, et al.
Published: (2012)

Promotion of chondrocyte function by inhibition of HIF-specific hydroxylases
by: Thoms, B, et al.
Published: (2010)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
by: Yeh, TL, et al.
Published: (2017)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Rasheduzzaman Chowdhury, et al.
Published: (2016-08-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
by: Tuckerman, JR, et al.
Published: (2004)

Therapeutic strategies that target the HIF system
by: Cook, K, et al.
Published: (2008)

The HIF pathway as a therapeutic target.
by: Hewitson, K, et al.
Published: (2004)

Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).
by: Cockman, M, et al.
Published: (2006)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
by: Mayer, M, et al.
Published: (2018)

Inhibition studies on hypoxia-inducible factor (HIF) hydroxylases
by: Chan, M
Published: (2014)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
by: Singh, A, et al.
Published: (2020)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
by: Astuti, D, et al.
Published: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
by: Moritz J. Strowitzki, et al.
Published: (2021-04-01)